Asiatic Laboratories Limited announcements
49 Dhaka Stock Exchange announcements for Asiatic Laboratories Limited (ASIATICLAB) since 2024: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2024 (17).
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.24 for July-September 2024 as against Tk. 0.92 for July-September 2023; NOCFPS was Tk. 0.60 for July-September 2024 as against Tk. 0.74 for July-September 2023. NAV per share with revaluation surplus was Tk. 52.82 as on September 30, 2024 and Tk. 52.58 as on June 30, 2024. NAV per share without revaluation surplus was Tk. 39.56 as on September 30, 2024 and Tk. 39.31 as on June 30, 2024.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 30, 2024 at 5:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
- Resumption after Record date
Trading of the shares of the company will resume on 21.11.2024.
- Suspension for record date
Trading of the shares of the company will remain suspended on record date i.e., 20.11.2024.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 18.11.2024 to 19.11.2024. Trading of the shares of the company will remain suspended on record date i.e., 20.11.2024.
- The Board of Directors has recommended No Dividend for the year ended June 30, 2023. Date of AGM: 19.12.2024, Time: 11:0
The Board of Directors has recommended No Dividend for the year ended June 30, 2023. Date of AGM: 19.12.2024, Time: 11:00 AM, Venue: Hybrid System. Record Date: 20.11.2024. The Company has also reported EPS of Tk. 2.19, NAV per share with revaluation surplus of Tk. 64.48, NAV per share without revaluation surplus of Tk. 45.94 and NOCFPS of Tk. 3.97 for the year ended June 30, 2023 as against Tk. 3.06, Tk. 59.68, Tk. 38.61 and 3.70 respectively for the year ended June 30, 2022.
- The Board of Directors has recommended 10\% Cash dividend only for General Shareholders excluding Sponsors & Directors f
The Board of Directors has recommended 10\% Cash dividend only for General Shareholders excluding Sponsors & Directors for the year ended June 30, 2024. The quantities of securities held by the said sponsors and/or directors who will not be entitled to recommended dividend: 49,828,490 shares. The amount payable to the general shareholders is Tk. 72,564,965.00. Date of AGM: 19.12.2024, Time: 11:30 AM, Venue: Hybrid System. Record Date: 20.11.2024. (cont.)
- Dividend Declaration
(Cont. news of ASIATICLAB): The Company has also reported EPS of Tk. 2.82, NAV per share with revaluation surplus of Tk. 52.58, NAV per share without revaluation surplus of Tk. 39.31 and NOCFPS of Tk. 3.15 for the year ended June 30, 2024 as against Tk. 2.19, Tk. 64.48, Tk. 45.94 and 3.97 respectively for the year ended June 30, 2023. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (31.10.2024) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 30, 2024 at 5:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
- Query Response
In response to the DSE query dated May 12, 2024, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike and increase in volume of shares.
- Query Response
In response to the DSE query dated March 24, 2024, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike and increase in volume of shares.
- Audited Annual Financial Statements of Asiatic Laboratories Limited for the year ended June 30, 2022: As per audited ann
Audited Annual Financial Statements of Asiatic Laboratories Limited for the year ended June 30, 2022: As per audited annual financial statements, profit after tax was BDT 268.56 million and basic EPS of BDT 3.06 for the year ended on 30 June 2022 as against profit after tax of BDT 320.52 million and basic EPS of BDT 3.65 for the year ended on 30 June 2021. However, Post-IPO basic EPS for the year ended on 30 June 2022 would be BDT 2.19. (cont.1)
- (Cont. news of ASIATICLAB): Pre-IPO Net Asset Value (NAV) per share with revaluation reserve and without revaluation res
(Cont. news of ASIATICLAB): Pre-IPO Net Asset Value (NAV) per share with revaluation reserve and without revaluation reserve would be BDT 59.68 & BDT 38.61(considering Pre-IPO paid up shares) respectively and Post-IPO Net Asset Value (NAV) per share with revaluation reserve and without revaluation reserve would be BDT 50.60 & BDT 35.48 (considering Post-IPO paid up shares) respectively. (cont.2)
The first part of this announcement is missing from the archive. - Trading of Shares of Asiatic Laboratories Limited
Trading of the shares of Asiatic Laboratories Limited will start at DSE from today i.e., March 06, 2024 under 'N' category. DSE Trading Code for Asiatic Laboratories Limited is "ASIATICLAB" and DSE Company Code is 18498 under 'Pharmaceuticals & Chemicals' sector.
- Audited Annual Financial Statements of Asiatic Laboratories Limited
(Cont. news of ASIATICLAB): Pre-IPO weighted average paid-up number of shares for the year ended on 30 June 2022 was 87,848,000 which was same for the previous year and Post-IPO paid-up number of shares would be 122,393,455. (end).
The first part of this announcement is missing from the archive. - Prohibition on providing loan facilities to purchase securities
DSE NEWS: The Stock Brokers, Merchant Bankers and Portfolio Managers are requested to abstain from providing loan facilities to purchase securities of Asiatic Laboratories Limited in between 1st to 30th trading day starting from today i.e., March 06, 2024 as per BSEC Directive No. BSEC/CMRRCD/2009-193/32 dated December 26, 2021.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.